Carregant...
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
BACKGROUND: Sunitinib has become mainstay first line treatment for patients with metastatic renal clear cell carcinoma (mRCC). Still, useful predictive markers of response are lacking and urgently needed for clinical decision making. METHODS: In the present study we investigated the predictive value...
Guardat en:
| Publicat a: | BMC Urol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580299/ https://ncbi.nlm.nih.gov/pubmed/28859644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0267-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|